Danske Bank A S Raises Stake in Astera Labs, Inc. $ALAB

Danske Bank A S raised its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 1,439.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 52,500 shares of the company’s stock after buying an additional 49,090 shares during the quarter. Danske Bank A S’s holdings in Astera Labs were worth $8,734,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs in the 4th quarter valued at approximately $33,000. National Bank of Canada FI grew its stake in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after buying an additional 124 shares during the period. Finally, Wexford Capital LP purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $39,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on ALAB. UBS Group began coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target for the company. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Citigroup began coverage on Astera Labs in a report on Thursday, April 2nd. They set a “buy” rating and a $200.00 price target for the company. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday. They set a “neutral” rating and a $153.00 price target for the company. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $250.00 price target on shares of Astera Labs in a report on Tuesday, April 21st. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $199.20.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $201.25 on Tuesday. The stock has a market capitalization of $34.47 billion, a P/E ratio of 164.96, a PEG ratio of 3.99 and a beta of 3.34. The company has a 50 day moving average price of $139.00 and a 200 day moving average price of $153.00. Astera Labs, Inc. has a fifty-two week low of $63.40 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the company posted $0.37 EPS. The firm’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief operating officer directly owned 1,531,301 shares in the company, valued at $189,590,376.81. This trade represents a 5.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares of the company’s stock, valued at $12,725,912.68. This represents a 7.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,064,888 shares of company stock worth $150,764,723 over the last ninety days. Company insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.